Comparing BRZE and CRM offers a clear view of two very different profiles within the software sector: a fast-growing but still loss-making customer engagement specialist and a dominant, deeply profitable enterprise CRM giant. The comparison has become especially timely because Salesforce recently agreed to acquire Braze, meaning the two companies' fortunes are now directly linked. Growth-oriented investors and traders tracking momentum, relative performance, and market positioning may find this side-by-side review useful for understanding what has driven each stock and how the acquisition reshapes their risk-and-reward profiles in the current market environment.
BRZE, or Braze, Inc., provides a cloud-based customer engagement platform that lets brands deliver personalized, real-time messaging across channels such as email, mobile apps, SMS, and web. The company serves roughly 2,800 customers, including well-known consumer brands, and recently reported approximately 9 billion monthly active users on its platform.
In its latest reported quarter, Braze grew revenue 26.2% year over year to about $227 million, while its operating loss narrowed compared with the prior year, signaling improving operating leverage. Braze has also leaned into AI through tools that automate message content, timing, and audience selection. Over recent weeks, the dominant driver of Braze's share price has been Salesforce's agreement to acquire the company for $47.50 per share in cash, a development that sent Braze stock sharply higher toward the offer price. Before the deal, sentiment had been mixed, as the company's strong growth was balanced against continued net losses.
CRM, or Salesforce, Inc., is the world's largest provider of cloud-based CRM software and a leader in enterprise applications spanning sales, service, marketing, and data. The company generates roughly $44 billion in trailing revenue and is firmly profitable, with a net margin above 20% and substantial free cash flow.
In recent quarters, Salesforce has emphasized AI through its Agentforce autonomous-agent platform and its Data 360 and Customer 360 offerings, positioning AI as a central growth engine. Revenue growth has moderated to a low-double-digit pace, a natural feature of its scale. In recent market activity, Salesforce shares have been pressured by a combination of acquisition announcements, including the roughly $5.66 billion deal for Braze, and investor debate over how quickly AI monetization will accelerate. The stock's pullback on the Braze announcement reflected short-term concerns about the cost of the transaction even as the company reaffirmed its near-term guidance.
Tickeron maintains a large library of AI Trading Bots that collectively trade thousands of different tickers, each built around distinct strategies, timeframes, risk profiles, and performance statistics. Because no single bot suits every market condition, Tickeron curates the most relevant performers into a dedicated Trending AI Robots section. This selection highlights the bots whose trading styles, win rates, and volatility characteristics currently align best with prevailing market dynamics, helping traders quickly identify AI-driven approaches without sifting through hundreds of options on their own. If you are looking for signal-driven, data-backed trading ideas across names like BRZE and CRM, exploring the curated Trending AI Robots list is a practical starting point.
The clearest contrast between these two names is scale and profitability. Braze is a focused, higher-growth business whose latest-quarter revenue rose 26.2% year over year, yet it still reports net losses as it invests in expansion. Salesforce is a diversified, mature platform growing at a more modest low-double-digit rate but converting that scale into a healthy profit margin and meaningful free cash flow.
Their risk profiles also differ. Braze's single-product focus gives it concentrated exposure to the marketing and engagement software segment, which makes its growth story compelling but less diversified. Salesforce's breadth across sales, service, marketing, data, and now AI agents spreads its exposure across a wider range of enterprise workloads, though its larger size limits the pace of expansion.
Market sentiment has diverged in recent weeks. Braze's shares re-rated toward the $47.50 cash offer, driven by acquisition certainty rather than operating fundamentals alone, which effectively caps further near-term appreciation absent a higher bid. Salesforce shares, by contrast, faced modest selling pressure as investors assessed the financial impact of the deal, even as the broader AI narrative around Agentforce remains a key catalyst. Valuation also differs sharply: Salesforce trades at a moderate earnings multiple with a dividend, while Braze's valuation reflects growth and deal pricing rather than current profitability.
Based on observable factors, Tickeron's AI would likely view these two stocks through different lenses. Braze currently exhibits strong trend consistency, but that momentum is largely anchored to a fixed acquisition price, meaning the signal is event-driven and its upside is bounded. Salesforce, while facing near-term consolidation after the deal announcement, retains a more durable, diversified market positioning with a longer runway tied to AI adoption. Probabilistically, the AI would lean toward Braze for short-horizon, deal-driven setups, while favoring Salesforce for stability and multi-quarter catalysts such as AI monetization and integration execution. The outcome depends heavily on the time horizon and risk tolerance applied to the analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
BRZE saw its Momentum Indicator move above the 0 level on September 30, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 79 similar instances where the indicator turned positive. In 66 of the 79 cases, the stock moved higher in the following days. The odds of a move higher are at 84%.
The Moving Average Convergence Divergence (MACD) for BRZE just turned positive on October 02, 2026. Looking at past instances where BRZE's MACD turned positive, the stock continued to rise in 29 of 35 cases over the following month. The odds of a continued upward trend are 83%.
BRZE moved above its 50-day moving average on October 07, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for BRZE crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 76%.
Following a +0.64% 3-day Advance, the price is estimated to grow further. Considering data from situations where BRZE advanced for three days, in 243 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 14 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BRZE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
BRZE broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BRZE entered a downward trend on October 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.679) is normal, around the industry mean (-1.734). P/E Ratio (-44.524) is within average values for comparable stocks, (15.183). Projected Growth (PEG Ratio) (1.207) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.074) among similar stocks. P/S Ratio (3.294) is also within normal values, averaging (71.128).
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. BRZE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BRZE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The Moving Average Convergence Divergence (MACD) for CRM turned positive on October 15, 2026. Looking at past instances where CRM's MACD turned positive, the stock continued to rise in 35 of 47 cases over the following month. The odds of a continued upward trend are 74%.
The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on CRM as a result. In 56 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.
Following a +3.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRM advanced for three days, in 222 of 324 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 68%.
CRM broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CRM entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. CRM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 48 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.367) is normal, around the industry mean (-1.734). P/E Ratio (22.878) is within average values for comparable stocks, (15.183). Projected Growth (PEG Ratio) (0.759) is also within normal values, averaging (2.824). Dividend Yield (0.007) settles around the average of (0.074) among similar stocks. P/S Ratio (5.107) is also within normal values, averaging (71.128).
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
CRM | ||
|---|---|---|
OUTLOOK RATING 1..100 | 23 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 71 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 48 | |
PRICE GROWTH RATING 1..100 | 38 | |
P/E GROWTH RATING 1..100 | 84 | |
SEASONALITY SCORE 1..100 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| BRZE | CRM | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 82% | N/A |
| Stochastic ODDS (%) | 1 day ago 78% | 1 day ago 68% |
| Momentum ODDS (%) | 1 day ago 84% | 1 day ago 67% |
| MACD ODDS (%) | 1 day ago 83% | 1 day ago 74% |
| TrendWeek ODDS (%) | 1 day ago 80% | 1 day ago 66% |
| TrendMonth ODDS (%) | 1 day ago 76% | 1 day ago 64% |
| Advances ODDS (%) | 1 day ago 80% | 10 days ago 69% |
| Declines ODDS (%) | 9 days ago 78% | 2 days ago 68% |
| BollingerBands ODDS (%) | 1 day ago 89% | 1 day ago 69% |
| Aroon ODDS (%) | 1 day ago 77% | 1 day ago 77% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BRZE’s FA Score shows that 1 FA rating(s) are green while CRM’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BRZE’s TA Score shows that 5 TA indicator(s) are bullish while CRM’s TA Score has 3 bullish TA indicator(s).
BRZE (@Packaged Software) experienced а +50.95% price change this week, while CRM (@Packaged Software) price change was +1.44% for the same time period.
The average weekly price growth across all stocks in the @Packaged Software industry was -0.42%. For the same industry, the average monthly price growth was -3.95%, and the average quarterly price growth was +4.32%.
BRZE is expected to report earnings on Dec 08, 2026.
CRM is expected to report earnings on Dec 02, 2026.
Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.
A.I.dvisor indicates that over the last year, BRZE has been closely correlated with HUBS. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if BRZE jumps, then HUBS could also see price increases.
| Ticker / NAME | Correlation To BRZE | 1D Price Change % | ||
|---|---|---|---|---|
| BRZE | 100% | +0.39% | ||
| HUBS - BRZE | 67% Closely correlated | +6.92% | ||
| CRM - BRZE | 66% Closely correlated | +3.52% | ||
| ASAN - BRZE | 64% Loosely correlated | +3.88% | ||
| CXM - BRZE | 63% Loosely correlated | +4.21% | ||
| FRSH - BRZE | 61% Loosely correlated | +3.34% | ||
More | ||||
A.I.dvisor indicates that over the last year, CRM has been closely correlated with NOW. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRM jumps, then NOW could also see price increases.
| Ticker / NAME | Correlation To CRM | 1D Price Change % | ||
|---|---|---|---|---|
| CRM | 100% | +3.52% | ||
| NOW - CRM | 78% Closely correlated | +2.53% | ||
| HUBS - CRM | 76% Closely correlated | +6.92% | ||
| ADBE - CRM | 75% Closely correlated | +6.07% | ||
| WDAY - CRM | 75% Closely correlated | +3.46% | ||
| FRSH - CRM | 71% Closely correlated | +3.34% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EUDV | 55.34 | 0.85 | +1.56% |
| ProShares MSCI Europe Dividend Growers ETF (EUDV) | |||
| IYH | 76.22 | 1.00 | +1.33% |
| iShares U.S. Healthcare ETF (IYH) | |||
| OVB | 19.78 | 0.09 | +0.46% |
| Overlay Shares Core Bond ETF (OVB) | |||
| STPZ | 52.51 | 0.21 | +0.40% |
| PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund (STPZ) | |||
| CRTC | 40.67 | -0.91 | -2.20% |
| Xtrackers US National Critical Technologies ETF (CRTC) | |||